NovaGo is focused on human antibody therapeutics targeting blood vessel & nerve growth. Our proprietary antibodies target Nogo-A, one of the most potent vascular & nerve growth inhibitors & have the potential to be a safe & effective treatment in ophthalmology and central nervous system indications.

Location

Wagistrasse 27, 8952 Schlieren, Switzerland

Facts & figures
  • Type of organization
    Private company
  • Year of foundation
    2015
  • Number of employees in Switzerland
    1-9
Key business